Temple Rock Holdings Inc.

CYNAPSUS ANNOUNCES RESULTS OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS
TORONTO, ONTARIO--(Marketwire - May 31, 2011) - Cynapsus Therapeutics Inc. (TSX VENTURE:CTH), a specialty pharmaceutical company developing an improved dosing formulation of an approved drug used to treat the symptoms of Parkinson's disease, today announced the results of its Annual and Special Meeting of Shareholders held earlier in the day, on May 31, 2011. MORE>>